Učitavanje...
The changing face of cancer treatments
This case demonstrates the effectiveness and ongoing potential of novel lung cancer therapies, specifically immunotherapy agents such as nivolumab, a T-cell programmed death 1 (PD-1) receptor inhibitor. In this case study, our patient had a significant burden of disease with nodal involvement above...
Spremljeno u:
| Izdano u: | BMJ Case Rep |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120638/ https://ncbi.nlm.nih.gov/pubmed/30173128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-224784 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|